PreS1-decorated recombinant adenovirus encoding HBV antigens generates neutralizing humoral and cellular immunity
Rebecca A Russell, James B. Lok, James Michael Harris, Senko Tsukuda, Louisa M. Rose, Bethany G. Charlton, Ivana Carey, Kosh Agarwal, Peter A. C. Wing, Sumi Biswas, Jane A. McKeating, Matthew D. J. Dicks
This study develops a vaccine using PreS1-decorated adenovirus that induces neutralizing antibodies and T-cell responses against HBV and HDV.
bioRxiv · Jan 30, 2026 · PreprintBioengineering